<DOC>
	<DOCNO>NCT02942394</DOCNO>
	<brief_summary>Primary objective : To assess efficacy stent ( sinus-Obliquus stent common iliac vein , sinus-XL Flex stent sinus-Venous stent external iliac common femoral vein ) evaluate different gradation patency rate , patient 's rating disease severity quality life patient post-thrombotic syndrome concomitant common iliac vein compression . Secondary objective : To assess long-term safety venous stenting</brief_summary>
	<brief_title>Treatment Postthrombotic Syndrome With Oblique Stent - TOPOS Study</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>May-Thurner Syndrome</mesh_term>
	<criteria>1 . Male female adult age â‰¥18 year 2 . Postthrombotic syndrome ( Villalta score &gt; 4 point ) due iliac vein thrombosis without femoral deep vein thrombosis 3 . Evidence venous stenosis common iliac vein &gt; 50 % confirm venography ( CT MRI ) intravascular ultrasound ( IVUS ) 4 . Use sinusObliquus stent unilateral common iliac vein stenosis 5 . If stent extension require either sinusXL Flex sinusVenous stent must use stenosis &gt; 50 % confirm venography ( CT MRI ) IVUS external iliac common femoral vein 1 . Pregnancy , breastfeed birthgiving last 30 day 2 . Life expectancy &lt; 6 month 3 . Iliofemoral DVT le 3 month ago 4 . Permanently immobile patient ( wheelchair user bedridden patient ) 5 . Allergy Nitinol 6 . Patient 's target vessel ( ) has/have stented 7 . Legal incapacity and/or circumstance render patient unable understand nature , scope possible impact study 8 . Patients custody juridical official order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>